Robert Naclerio to Rhinitis
This is a "connection" page, showing publications Robert Naclerio has written about Rhinitis.
Connection Strength
10.807
-
Unblocking the Treatment Stalemate in Chronic Rhinosinusitis Without Nasal Polyposis (CRSsNP). J Allergy Clin Immunol Pract. 2024 Apr; 12(4):1062-1064.
Score: 0.792
-
A Decade of Clinical Advances in Chronic Rhinosinusitis: 2012-2022. J Allergy Clin Immunol Pract. 2023 01; 11(1):43-50.
Score: 0.727
-
Management of the Upper Airway Distress During Pregnancy. Immunol Allergy Clin North Am. 2023 02; 43(1):53-64.
Score: 0.718
-
The Treatment Paradigm of Chronic Rhinosinusitis with Nasal Polyps in the COVD-19 Era. J Allergy Clin Immunol Pract. 2020 09; 8(8):2492-2494.
Score: 0.610
-
Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics: A National Institute of Allergy and Infectious Diseases Workshop. J Allergy Clin Immunol Pract. 2020 05; 8(5):1532-1549.e1.
Score: 0.597
-
A Pragmatic Approach Towards Sinonasal Diseases. J Allergy Clin Immunol Pract. 2020 05; 8(5):1556-1558.
Score: 0.595
-
Persistence of Sinonasal Disease Despite Mepolizumab. J Allergy Clin Immunol Pract. 2020 05; 8(5):1550-1555.
Score: 0.594
-
Other Phenotypes and Treatment of Chronic Rhinosinusitis. J Allergy Clin Immunol Pract. 2016 Jul-Aug; 4(4):613-20.
Score: 0.463
-
Diagnostic algorithm for unilateral sinus disease: a 15-year retrospective review. Int Forum Allergy Rhinol. 2015 Jul; 5(7):590-6.
Score: 0.426
-
A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis. Rhinology. 2010 09; 48(3):318-24.
Score: 0.309
-
Serum 25-hydroxyvitamin D levels are lower in urban African American subjects with chronic rhinosinusitis. J Allergy Clin Immunol. 2008 Aug; 122(2):415-7.
Score: 0.266
-
Effect of topical ciprofloxacin/dexamethasone or dexamethasone alone on acute Streptococcus pneumoniae rhinosinusitis in mice. Otolaryngol Head Neck Surg. 2008 Mar; 138(3):340-6.
Score: 0.260
-
Cold air-induced rhinitis. Clin Allergy Immunol. 2007; 19:267-81.
Score: 0.240
-
Environmental and allergic factors in chronic rhinosinusitis. Clin Allergy Immunol. 2007; 20:25-49.
Score: 0.240
-
Allergic rhinitis augments the response to a bacterial sinus infection in mice: A review of an animal model. Am J Rhinol. 2006 Sep-Oct; 20(5):524-33.
Score: 0.234
-
Persistent inflammation and hyperresponsiveness following viral rhinosinusitis. Laryngoscope. 2006 Jul; 116(7):1236-40.
Score: 0.231
-
The effect of treatment with moxifloxacin or azithromycin on acute bacterial rhinosinusitis in mice. Int J Infect Dis. 2006 Sep; 10(5):401-6.
Score: 0.227
-
Total IgE levels do not change 1 year after endoscopic sinus surgery in patients with chronic rhinosinusitis. Int Arch Allergy Immunol. 2006; 139(2):146-8.
Score: 0.223
-
Acute bacterial rhinosinusitis causes hyperresponsiveness to histamine challenge in mice. Arch Otolaryngol Head Neck Surg. 2005 Oct; 131(10):905-10.
Score: 0.220
-
Chronic Rhinosinusitis of Odontogenic Origin. J Allergy Clin Immunol Pract. 2021 Jul; 9(7):2894-2895.
Score: 0.164
-
International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021 03; 11(3):213-739.
Score: 0.160
-
Bactrim reduces the inflammatory response in a murine model of acute rhinosinusitis. Rhinology. 2000 Jun; 38(2):68-71.
Score: 0.152
-
Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNP. Rhinology. 2020 Feb 01; 58(1):10-17.
Score: 0.148
-
Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis. Allergy. 2020 01; 75(1):148-157.
Score: 0.146
-
Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma. J Allergy Clin Immunol Pract. 2019 Sep - Oct; 7(7):2447-2449.e2.
Score: 0.140
-
A mouse model of acute bacterial rhinosinusitis. Arch Otolaryngol Head Neck Surg. 1998 Nov; 124(11):1227-32.
Score: 0.136
-
Rhinitis and inhalant allergens. JAMA. 1997 Dec 10; 278(22):1842-8.
Score: 0.128
-
International Consensus Statement on Allergy and Rhinology: Rhinosinusitis. Int Forum Allergy Rhinol. 2016 Feb; 6 Suppl 1:S22-209.
Score: 0.112
-
Cold dry air-induced rhinitis: effect of inhalation and exhalation through the nose. J Appl Physiol (1985). 1995 Aug; 79(2):467-71.
Score: 0.109
-
Effect of prednisone on nasal symptoms and peripheral blood T-cell function in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2014 Aug; 4(8):609-16.
Score: 0.099
-
Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2013 Jun; 131(6):1479-90.
Score: 0.093
-
Peripheral blood and tissue T regulatory cells in chronic rhinosinusitis. Am J Rhinol Allergy. 2012 Sep-Oct; 26(5):371-9.
Score: 0.089
-
Local application of atropine attenuates the upper airway reaction to cold, dry air. Am Rev Respir Dis. 1992 Aug; 146(2):340-6.
Score: 0.088
-
Steroid-induced reduction of histamine release does not alter the clinical nasal response to cold, dry air. Am Rev Respir Dis. 1991 Apr; 143(4 Pt 1):761-5.
Score: 0.080
-
Studies on the relationships between sensitivity to cold, dry air, hyperosmolal solutions, and histamine in the adult nose. Am Rev Respir Dis. 1990 Jun; 141(6):1428-33.
Score: 0.076
-
Diagnosis and management of chronic rhinosinusitis in adults. Postgrad Med. 2009 Nov; 121(6):121-39.
Score: 0.073
-
A genomewide screen for chronic rhinosinusitis genes identifies a locus on chromosome 7q. Laryngoscope. 2008 Nov; 118(11):2067-72.
Score: 0.068
-
The osmolality of nasal secretions increases when inflammatory mediators are released in response to inhalation of cold, dry air. Am Rev Respir Dis. 1988 Mar; 137(3):625-9.
Score: 0.065
-
Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis. 1988 Mar; 137(3):613-6.
Score: 0.065
-
Development and validation of the Congestion Quantifier seven-item test (CQ7): a screening tool for nasal congestion. Value Health. 2007 Nov-Dec; 10(6):457-65.
Score: 0.063
-
Rhinosinusitis: Developing guidance for clinical trials. Otolaryngol Head Neck Surg. 2006 Nov; 135(5 Suppl):S31-80.
Score: 0.059
-
Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol. 2006 Nov; 118(5 Suppl):S17-61.
Score: 0.059
-
Inflammatory mediators in nasal secretions during induced rhinitis. Clin Allergy. 1986 Mar; 16(2):101-10.
Score: 0.057
-
Rhinosinusitis: Establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg. 2004 Dec; 131(6 Suppl):S1-62.
Score: 0.052
-
Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol. 2004 Dec; 114(6 Suppl):155-212.
Score: 0.052
-
Antiallergic effects of H1-receptor antagonists. Allergy. 2000; 55 Suppl 64:17-27.
Score: 0.037
-
Comparison of nasal mucosal responsiveness to neuronal stimulation in non-allergic and allergic rhinitis: effects of capsaicin nasal challenge. Clin Exp Allergy. 1998 Jan; 28(1):92-100.
Score: 0.032
-
Monoclonal Antibodies for the Treatment of Nasal Polyps. Immunol Allergy Clin North Am. 2017 05; 37(2):357-367.
Score: 0.030
-
Inhibition of the response to nasal provocation with bradykinin by HOE-140: efficacy and duration of action. Can J Physiol Pharmacol. 1995 Jul; 73(7):820-6.
Score: 0.027
-
Ipratropium bromide (Atrovent nasal spray) reduces the nasal response to methacholine. J Allergy Clin Immunol. 1992 Jun; 89(6):1065-75.
Score: 0.022
-
Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. Int Arch Allergy Immunol. 2012; 158(3):216-31.
Score: 0.021
-
Histamine stimulation of the nasal mucosa does not induce prostaglandin or leukotriene generation or induce methacholine hyperresponsiveness. Int Arch Allergy Appl Immunol. 1991; 95(2-3):149-55.
Score: 0.020
-
The effects of H1 antihistamines on the early allergic response. Ann Allergy. 1989 Dec; 63(6 Pt 2):551-5.
Score: 0.018
-
Studies on the allergic and nonallergic nasal inflammation. J Allergy Clin Immunol. 1988 May; 81(5 Pt 1):782-90.
Score: 0.016
-
In vivo release of inflammatory mediators by hyperosmolar solutions. Am Rev Respir Dis. 1988 Mar; 137(3):606-12.
Score: 0.016
-
Theophylline reduces the response to nasal challenge with antigen. Am J Med. 1985 Dec 20; 79(6A):43-7.
Score: 0.014
-
Mediator release during nasal provocation. A model to investigate the pathophysiology of rhinitis. Am J Med. 1985 Dec 20; 79(6A):26-33.
Score: 0.014
-
Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest. 1985 Oct; 76(4):1375-81.
Score: 0.014
-
Sinusitis: bench to bedside. Current findings, future directions. J Allergy Clin Immunol. 1997 Jun; 99(6 Pt 3):S829-48.
Score: 0.008
-
Sinusitis: bench to bedside. Current findings, future directions. Otolaryngol Head Neck Surg. 1997 Jun; 116(6 Pt 2):S1-20.
Score: 0.008
-
The role of kinins in human allergic disease. N Engl Reg Allergy Proc. 1986 May-Jun; 7(3):213-8.
Score: 0.004
-
The pharmacologic control of mediator release from human basophils and mast cells. Respiration. 1986; 50 Suppl 2:116-22.
Score: 0.003